tolerance could be due to specific suppressor T cells of cytokine producing, graft infiltrating cells are not antigen-specific [14] . Cytokines which are detected by that might migrate into the target tissue and release Th2 regulatory cytokines into the local environment.
immunohistochemistry can bind to receptor-positive cells in addition to cells that actively produce the cytokines. Although IL-2 mRNA was detectable in
Variability of intragraft cytokine gene expression
renal allografts of rats made tolerant by donor-specific transfusion, graft infiltrating cells failed to produce associated with allograft rejection IL-2 protein upon restimulation [15] . Recently, expression of some chemokine receptors was found to be If one assumes that a Th1-dominated immune response specific for CD4+ T cell subsets: Th2 lymphocytes is responsible for allograft rejection, a pattern of Th1 preferentially express CCR3, whereas CCR5 is cytokines should be detectable in the rejecting graft expressed at high levels on Th1 and is virtually absent in the absence of typical Th2-associated cytokines.
on Th2 cells [16, 17] . These cell surface markers Indeed, it was reported that rejection of murine pancremay allow more accurate analysis of Th1-or atic islet allografts was characterized by intragraft IL-2 Th2-dominance on the basis of individual cells. and IFN-c expression, whereas IL-4 mRNA was not detected [9] . However, rejection of human renal allografts was found not to be associated with enhanced
Manipulation of the Th15Th2 balance in
expression of intragraft IL-2 [10] . Another group experimental transplantation detected IL-4 in rejecting and rejected renal allografts [11] . Upregulation of both Th1 (IL-2, IFN-c) and Th2 (IL-4 and IL-10) cytokines have been detected in The hypothesis that preferential induction of Th2 response would promote allograft survival is based on spontaneously accepted mouse liver allografts [12] . In another study, however, these cytokines (IL-2, IL-4 the ability of Th2 cytokines to down-regulate Th1 polarization and function [5] . IL-10 is one of the Th2 and lymphotoxin) were reported to be expressed only in rejecting allografts [13] .
cytokines which has been intensively investigated in transplantation models. Indeed, allograft survival of There are several problems that might lead to misinterpretations of intragraft cytokine expression pattern. non-vascularized murine neonatal cardiac transplants was prolonged after transduction with viral IL-10 gene Immunohistochemistry analysis and detection of cytokine mRNA do not take into account that the majority [18] . However, mice treated with chimeric proteins containing IL-10 showed accelerated rejection of islet of the immune response toward a polarized Th2 type and this may be achieved for example by blocking cell allografts [19] . An explanation could be that IL-10 exhibits not only immunosuppressive effects. IL-10 co-stimulation pathways. also augments IL-2 supported proliferation of CD8+ T cells and enhances IL-2-induced cytotoxicity by these References cells. The other cytokine supporting a Th2 polarized immune response is IL-4. However, transfection of 2 -vitamin D [6] [7] [8] . In duced not only in bone and cartilage as its name the normal kidney osteopontin is constitutively implies, but also in the kidney, hence its alternative expressed by segments of the loop of Henle, the distal name uropontin [1, 2] . Osteopontin is encoded by a tubule and by the papillary and pelvic epithelium of single gene which contains seven exons and six introns, the renal fornix, with some differences in mouse, rat and it maps to human chromosome 4q22 and mouse and human [9] [10] [11] [12] . Being secreted by these distal chromosome 5. Several splice variants have been nephron segments and the urothelium, osteopontin is described. The 5∞-flanking region of the osteopontin also found in the urine [13] . gene contains numerous consensus sequences for transcription factors, including a vitamin D-response ele-
The diverse roles of osteopontin ment ( VDRE), a glucocorticoid response element (GRE ), a ras-responsive element (RRE) and several Osteopontin is a calcium-binding protein and plays an AP-1 (c-jun-c-fos heterodimer) binding sites [3] . These essential role in regulating bone mineralization [1] . transcription factor recognition sites explain the com-Osteopontin inhibits calcium oxalate and hydroxyapatplex regulation of osteopontin expression by vitamin ite growth in vitro and acts as an inhibitor of stone D, growth factors, cytokines and phorbol esters. formation [14, 15] . Calcium oxalate crystals can bind Transcription of the osteopontin gene results in a directly to kidney tubular epithelial cells and stimulate protein with~300 amino acids in most species. osteopontin synthesis, thereby possibly limiting further Osteopontin is a secreted phosphoprotein which con-crystallization [16, 17] . Being present in the urine, ostetains two calcium-and two heparin-binding sites, and opontin could act as an inhibitor of kidney stone an Arg-Gly-Asp (RGD) cell adhesion motif. The formation in vivo [13, 18, 19] . Indeed, osteopontin has RGD sequence is required for binding of osteopontin been found in calcium oxalate kidney stones. to integrin receptors. The principal integrin which It has been suggested that osteopontin could also be binds osteopontin is the vitronectin receptor a v b 3 . an inhibitor of tissue calcification through its ability Additional receptors include the integrins a v b 1 and to bind calcium at high capacity and low affinity [2] . a v b 5 and the hyaluronan receptor CD44 [4, 5] .
Osteopontin is found at sites of calcification in atherosclerotic plaques and calcified aortic valves where it possibly could limit further calcium deposition.
Osteopontin expression in cells and in the normal
Osteopontin has also been found to be associated with renal disease has been linked to chemotaxis by osteo-phage influx after unilateral ureteral obstruction was significantly reduced in the osteopontin KO mice compontin [23] , and VSMC migration in response to osteopontin could be important in the pathogenesis of pared with control mice [45] . Osteopontin is certainly not the only chemotactic protein involved in macroatherosclerotic plaque formation [2] . Subcutaneous injection of purified osteopontin results in a macro-phage accumulation, and additional proteins such as the chemokines do play a significant role as well. phage-rich infiltrate [24, 25] . Furthermore, osteopontin is found abundantly in granulomatous lesions such as Whether osteopontin is important in human tubulointerstitial inflammation and whether it functions as a tuberculosis and silicosis, which also suggests a role for osteopontin in macrophage infiltration and granul-macrophage chemoattractant in man will need to be determined in future studies. oma formation [26 ] .
Recent studies have pointed to yet another role for osteopontin, namely its antagonism of nitric oxide
References
(NO) synthesis. In studies examining inducible NO synthase (iNOS ) expression in mouse and human 1 Introduction expression of the immunosuppressive cytokine, transGlucocorticoids (GCs) are used in treating disorders forming growth factor ( TGF )-b. Similar to GCs, TGFof heightened immunity such as transplant rejection, b is a pleiotropic mediator that modulates several owing to their capacity to prevent T cell activation by aspects of the inflammatory response, and is a potent suppressor of T cell activation and cytokine expression. 
TGF-b: supporting views
In view of the inducibility of TGF-b expression by GCs, and the similarities between GCs inhibitory
Mode of action of glucocorticoids
effects on cytokine expression and T cell activation and those induced by TGF-b, it was speculated that GCs indirectly mediate their anti-proliferative effect by induDespite their wide-spread use, the mechanism by which cing TGF-b expression [3, 6, 7] . This conclusion was GCs exert their anti-inflammatory and immunobased on the findings that: (i) the synthetic GC, suppressive effects is not completely understood. It is dexamethasone (DEX ), up-regulated TGF-b mRNA well appreciated that these effects involve both direct expression in non-stimulated [3] and mitogen-activated and indirect events [1] . In this regard, GCs reportedly T cells [3] , fibroblasts [8] , osteoblasts [9] , macrophages act directly by: (i) blocking proximal events of T cell [1] , and other cells [6, 7] in a concentration and time receptor ( TcR) signal transduction; (ii) inhibiting the dependent manner and, (ii) GCs anti-proliferative expression of leukocyte adhesion molecules and; effect was abrogated by neutralizing anti-TGF-b anti-(iii) suppressing cytokine production and action [1, 2] .
bodies [3, 7] . In addition to these direct effects, GCs act indirectly GCs upregulation of TGF-b expression was a rapid by: (i) inducing synthesis of lipocortin which inhibits event, being detected as early as 1 h after GCs addition, phospholipase A2 activity, and hence the release of peaking at 4-6 h, and persisting for up to 24 h postarachidonic acid from membrane-bound stores and the GCs addition. Induction of TGF-b expression by GCs ensuing production of eicosanoids, (ii) promoting a occurred at the transcriptional [7, 8] and postTh2 cell activity through preferential blockade of Th1 transcriptional [6, 9] levels; the latter involving stabilcytokines, thus precipitating a long-lasting state of ization of TGF-b mRNA, largely as a result of tolerance and, (iii) inducing the expression of TGF-b, antagonism of TGF-b specific RNases [3] . In addition, an immunosuppressant cytokine which blocks cytokine upregulation of TGF-b expression potentiated GCs synthesis and hence T cell activation [1, 3] . Depending transcriptional repression at the level of GCs receptor on the target cell and the specific conditions of activacomplex interaction with the GCs responsive elements tion, GCs may utilize more than one of the afore-(GRE ) DNA sites, thereby constituting a feedback mentioned mechanisms in exerting their effects.
system between TGF-b and GCs and resulting in profound immunosuppression.
TGF-b as an immunosuppressant Mediation of the effects of glucocorticoids by TGF-b: opposing views
TGF-b is a highly conserved 25 kDa protein produced by mitogen-activated T cells, B cells, monocytes, and fibroblasts [3] , and exerts predominantly immuno-In spite of evidence implicating induction of TGF-b suppressive effects on the growth and function of as a mechanism by which GCs mediate their anti-T cells, B cells, and other mononuclear leukocytes [4] . proliferative effects, other reports provided arguments Its production by activated T cells was suggested as against direct involvement of TGF-b in GCs antione mechanism by which T cells limit their response proliferative effects. This was based on the findings to a particular stimulation [5] . that GCs did not upregulate TGF-b mRNA expression Although the mechanism by which TGF-b exerts its or protein secretion [1] , but rather suppressed its immunosuppressive effects remains elusive, recent evid-expression. In addition, GCs reportedly antagonized a ence suggests that the site of action of TGFb is distal number of TGF-b effects, such as induction of prostato IL-2 production [5] , involving inhibition of the glandin synthesis and expression of the procollagen expression of high-affinity cytokine receptors and sig-gene [10] . Furthermore, the mechanism of action of nalling through cytokine receptors largely as a result GCs was distinct from that of TGF-b, as revealed by of blockade of Jak-Stat signal transduction pathway the opposing effect of TGF-b and GCs (DEX ) on [5] . Furthermore, by preferentially suppressing Th1 induced nitric oxide synthetase mRNA expression but not Th2 cytokine production and stimulating IL-10 stimulated by IL-1 [11], procollagen synthesis (inhibaccumulation [4] , TGFb converts the immune response ited by GCs but stimulated with TGF-b) [12] and from a Th1-to a Th2-like phenotype [4] , hence alleviat-EGF-induced c-fos mRNA expression (inhibited by ing Th1-mediated disorders such as allograft rejection GCs but resistant to TGF-b). It is noteworthy that, and autoimmunity. It remains to be determined while GCs anti-proliferative effect required continued whether promotion of Th2 activity by TGF-b is the GCs presence since removal of GCs results in enhanced resultant of its co-expression with Th2 cytokines (and cytokine secretion and augmented T cell proliferation, hence its mis-classification as a Th2 cytokine), as was that induced by TGF-b did not require its continued suggested, or due to frank transcriptional repression presence, as removal of TGF-b did not restore T cell proliferation. Thus, induction of TGF-b by GCs and, of Th1 cytokines. 
Introduction The diagnostic utility of biopsy
There are few doubts that the clinical and biological Renal biopsy is being used extensively in systemic data are generally sufficient for diagnosing SLE nephlupus erythematosus (SLE ). However, there is not ritis. However, renal biopsy is the only tool that complete agreement about the need for renal biopsy permits the correct classification of lupus nephritis. An at presentation. Some physicians argue that the clinical SLE patient with haematuria, proteinuria and normal diagnosis of lupus nephritis is easy and that the proor subnormal renal function may have any class of gnosis and treatment may be assessed without the underlying glomerular lesions and unpredictable seversupport of histological features. Even more controverity of histological lesions. This may imply a different sial are the indications to repeat biopsy in patients prognosis and different therapeutic approaches. with established lupus nephritis.
Moreover, there are instances in which the diagnosis can be difficult. A few patients may present initially with renal disease and only exhibit systemic and biol- is relatively frequent for patients with an underlying membranous nephritis. In some cases, the biological nephritis? We feel exactly the opposite. The fact that markers of SLE may be absent for years and the the different classes of SLE nephritis may now have a differential diagnosis between idiopathic and SLE similar outcome is not due to the lack of prognostic membranous nephritis can be established only by differences but rather is caused by the choice of treating biopsy, which may show mesangial immune deposits, patients showing a severe histological pattern with endothelial tubuloreticular inclusions, the typical virus-appropriately aggressive therapies tailored on the basis like particles, and sometimes subendothelial deposits. of biopsy. In the early 1960, Pollak et al. [6 ] provided A different situation is represented by those patients evidence that low-dose corticosteroids were unable to who have no clinical evidence of renal involvement stop the downhill course of type IV nephritis while despite underlying glomerular lesions at biopsy. high-dose corticosteroids could improve the outcome Usually, this silent nephritis is characterized by mes-of this disease. Since then, several therapeutical angial or mild focal proliferative lesions but, exception-approaches have been suggested, but the principle has ally, it may be associated with a diffuse proliferative been the same: patients with diffuse proliferative glomglomerulonephritis. erulonephritis should be treated aggressively in order to reach a clinical and histological quiescence of lupus activity. This approach has allowed excellent results to
The prognostic role of renal biopsy be achieved. While in the past most patients died or developed renal failure within 2 years of clinical onset In the past, it has been well documented that glomer-(mainly because of undertreatment), more recent data ular pathology is a reliable prognostic indicator in reported a 10 year renal survival of~90% in patients SLE. Older studies found a good correlation between with class IV nephritis, at least in some series [3, 4] . the WHO classification and the short-term renal out-One of the main reasons for this dramatic improvement come. Of the five classes devised in the 1970s, patients is that physicians realized how important adequate with minimal changes (class I ), pure mesangial lesions treatment is in patients with a biopsy-proven diffuse (class II ) or focal proliferation limited to few glomeruli proliferative nephritis and elevated activity index, even (class III ) were found to have little probability of when the clinical presentation is not too severe. progression, independently of the type of treatment. However, in several cases, it can be difficult to assess More controversial was the prognosis for membranous the severity of the underlying renal lesions on clinical glomerulonephritis (class V ) which was usually consid-grounds only. An SLE patient with moderate urine ered to be an indolent disease although a review of the signs may have a class IV lupus nephritis and active literature reported that 50 of 136 patients (36.7%) histological lesions. Inadequate treatment may favour either died or developed renal failure [1] . There was the transformation of active lesions into sclerotic irreconsensus that patients with extended focal prolifera-versible lesions. On the other hand, SLE patients with tion and those with diffuse proliferative glomerulo-increased plasma creatinine may have important nonnephritis (class IV ) had the worst prognosis, but with glomerular lesions but only mild glomerular lesions marked variability in the clinical course. Because of that do not necessitate aggressive therapy [7] . Thus, if this, efforts have been made to better define the histo-the clinical assessment remains the cornerstone for logical features associated with a poor renal prognosis planning therapy, renal biopsy can add vital informain patients with SLE nephritis. The original WHO tion. A cautious approach may be justified in patients classification was expanded by adding several sub-with class II and mild class III nephritis, although classes which took into account the extension of active these patients must be followed carefully to catch and sclerosing lesions. This reinforced the prognostic possible transformations into more severe renal disease. significance of renal biopsy. A further contribution Conversely, patients with extensive focal proliferation was made by the introduction of the so-called activity or with class IV nephritis should be treated aggressively and chronicity indices which summed the semiin order to prevent irreversible lesions. quantitative scores of certain histological features. The
The same considerations are valid for the so-called Bethesda group [2] reported that the semi-quantitative activity and chronicity indices. The fact that several index of activity (which considered florid, potentially groups, including ourselves [3] , could not find any reversible, lesions such as fibrinoid necrosis, cell prolifcorrelation between the activity index at initial biopsy eration, interstitial inflammation, etc.) and the index and renal outcome is not an argument against the of chronicity (which considered irreversible lesions prognostic significance of this parameter. Rather it is such as glomerular sclerosis, interstitial fibrosis, etc.) a further proof of how much an appropriate treatment could predict the risk of renal failure and orientate the can stop the natural progression to renal failure in therapy better than the WHO classification alone.
patients with an active form of lupus nephritis. On the Recently, a number of studies reported an excellent other hand, the lack of correlation between chronicity long-term renal survival in patients with class IV index and renal outcome in some series may be nephritis, no different to that seen in patients with explained by the fact that the mean chronicity index class II or III [3, 4] . Other investigators were unable to had low values so that it was unlikely that mild chronic duplicate the results of the Bethesda group with the lesions could influence the outcome. In other series, use of activity and chronicity indices [5] . Does this mean that renal biopsy is useless in patients with lupus the follow-ups were too short to see the unfavourable impact of an elevated chronicity index, which may Conclusions occur in the long-term.
Renal biopsy has a paramount role in the management of patients with lupus nephritis. No clinical or biological feature at onset uniformly predicts renal morpho-
Should renal biopsy be repeated?
logy, particularly the extent of renal lesions. In contrast, kidney biopsy can allow a correct diagnostic With the prolonged survival of patients with lupus framing and can orientate the most appropriate treatnephritis, the potential of histological findings at initial ment. This has certainly contributed to the considerrenal biopsy to predict long-term renal prognosis has ably improved prognosis of SLE nephritis. diminished. It is well known that transformations from
Whether and when renal biopsy should be repeated one class to another can be observed in up to 50% of in SLE patients are still far from being established. repeat biopsies. Moreover, the signs of activity or Excellent results can be obtained by intensive clinical chronicity may vary considerably over time as a con-monitoring which allows prompt and aggressive treatsequence of the disease and its treatment [8] . Thus, it ment of renal flares, characterized either by an increase is difficult to know whether the histological presenta-in plasma creatinine or by an increase in urine protein tion at initial renal biopsy remains or not the same excretion [10] . However, only repeat renal biopsy over the time in a particular patient.
allows the establishment of the long-term prognosis Unfortunately, little attention has been paid in the and the taking of important therapeutic decisions in literature to the prognostic value of serial renal biopsies particular cases. A good correlation between clinical in patients with lupus nephritis. This is due in part to signs and histology is usually found in patients with reluctance to repeat an invasive procedure which is clinical improvement. Stable histological features are not without potential complications. We feel that there usually seen in patients with persistent nephrotic synare at least three main clinical settings, in which a drome. Conversely, the histological picture in patients repeat renal biopsy may provide useful information with impaired renal function is unpredictable. In these for the clinician. Group A: improvement in renal particular patients who are those at the highest risk of disease with persistent proteinuria. In this case, biopsy irreversible uraemia, repeat renal biopsy is not only may help in deciding whether or not to reduce or even fully justified, but is almost mandatory in order to discontinue therapy. Group B: persistent or relapsing evaluate whether or not to subject them to further nephrotic syndrome. Here biopsy may allow one to aggressive treatments. see whether or not there has been a transformation and whether or not immunosuppression should be increased. Group C: slow worsening of renal function.
Renal biopsy is the only investigation that is able to References predict whether it may be worth administering aggressive therapy to reverse renal dysfunction.
Introduction
Klebsiella, Pseudomonas and Proteus species [4] . Infections with staphylococci [5] and streptococci [2] With a prevalence of 15500-151000, autosomal dominare rare, tuberculous and fungal disease even more so. ant polycystic kidney disease (ADPKD) accounts for
The potential for haematogenous infection is supported 4-10% of patients on dialysis. Significant advances in by occasional reports, for example, of staphylococcal the genetics and pathophysiology of ADPKD have infection of a cyst in an intravenous drug abuser [5] . been made over the years, and its complications are Anaerobic infection is uncommon, but perinephric well documented. Infection remains one of the comabscesses [3] and aspirated cyst fluid have grown monest of these.
anaerobes [6 ] ; the finding of low oxygen tensions within some cysts would support the potential for anaerobic infections [4] .
Lower urinary tract infection and pyocystis

Symptomatic lower urinary tract infection affects Clinical presentation
50-75% of all polycystic patients at some time.
Treatment is simple and the condition is usually Infection of the lower urinary tract and acute pyelouncomplicated. Infection of the upper urinary tract is nephritis in a patient with polycystic kidney disease different, however. An autopsy study by McNamara are not usually diagnostic dilemmas; the same cannot in 1965 showed evidence of pyelonephritis in 56% of be said for pyocystis. The clinical presentation is patients with ADPKD, even though clinical sepsis was classically that of a discrete area of tenderness relating not considered to be significant in many of these cases to one kidney. Torsion of or haemorrhage into a cyst [1] . The infection of a single cyst within a polycystic may, however, present similarily. A more difficult kidney-pyocystis-is a well-recognized and poten-challenge is the assessment of the significance of bactially serious complication of ADPKD. teraemia in an ADPKD patient with only equivocal Cyst infection probably originates from the lower clinical signs. Many cysts do not communicate with urinary tract, a theory that is supported by the observa-the rest of the urinary tract and, therefore, associated tion that up to 92% of upper tract infections occur in lower urinary tract symptoms and bacteriuria may be females [2] . The infecting organisms are very similar absent. In a series of 15 such patients investigated by to those causing lower urinary tract infections-the Schwab [2] , however, attempts to isolate an organism enterobacteriacea. Treatment can be difficult, and signi-from blood and urine were always successful. ficant morbidity, mortality and complications, notably Furthermore, four patients from this group required the development of perinephric abscesses, have been nephrectomy which confirmed that cyst infection was described [3] . Diagnosis is not always simple, and caused by the same organism as that in blood or urine. supportive diagnostic aids such as imaging modalities If necessary, puncture of a suspicious cyst under ultraare lacking. The choice of antibiotic for use in cyst sonographic guidance may also be diagnostic. infection can be difficult because of uncertainty over the diagnosis, penetration of antibiotics into cysts and fluid, and potentially resistant organisms. Sporadic Diagnostic problems research on the topic was reported from 1981 to the early 1990s, but interest in the topic has waned. It is Diagnostic imaging is often less helpful than might be therefore timely to re-examine this work.
expected. Despite advances in available modalities, imaging of polycystic kidneys remains a problem, and attempts to find a single infected cyst therein is a
The microbes 'radiologist's nightmare'. Polycystic kidneys often contain multiple cysts with very different contents, and Microbiological results from small case series and pus and organizing haematomas can look very similar anecdotal reports confirm that the commonest organ-when scanned. Ultrasound, computed tomography and magnetic resonance imaging scanning image cystic 
alkaline pK a of 7.45 [8] . At a physiological pH, unbound drug will be almost one half ionized and one half not; being a lipophilic antibiotic, the non-ionized
Penetration of antibiotics into cysts
half will move relatively freely into cysts. Once inside a cyst, an acidic environment would result in ionization of the previously non-ionized half, thus making backAntibiotic treatment of infected cysts has variable effects; cure can be rapid, but resistant infection requir-diffusion out of the cyst difficult (ion trapping).
Extrapolation of this concept would also suggest that ing radical intervention has been described. The reason for this is thought to relate to the transport character-anionic antibiotics, notably the b-lactams (which are also lipophobic), would not enter an acidic cyst. The istics of individual cysts and was first studied in detail by Muther and Bennett, who aspirated and analysed conclusion from this work was that drugs with an alkaline pK a should be used for cyst infections but, the contents of individual cysts from polycystic kidneys removed at nephrectomy or autopsy [7] . In each case, with cyst pH varying from 5 to 7.6, it is hard to be dogmatic with regards to this. Clindamycin levels in antibiotics had been given for 36-48 h before operation, but in only two cases was there thought to be an cysts of neutral pH approached very low levels comparable with the lipophobic antibiotic gentamicin; the infected cyst. By calculating the cyst5serum sodium ratio, all cysts were divided into proximal (ratio>0.9) benefit of the higher pK a is obviously lost in this situation. or distal (<0.2). Analyses of antibiotic concentrations in these cysts demonstrated that gentamicin, tobramycin and ticarcillin were undetectable in distal cysts, and
Practical guidelines for the selection of antibiotics
only cephapirin was found in these cysts. Tobramycin was not found in proximal cysts either, whilst gentamicin and ticarcillin were. These findings bring into What, therefore, are the ideal characteristics of an question the mechanism by which antibiotics might antibiotic for use in cyst infection? In the absence of enter cysts. microbiological sensitivities, activity against GramMicrodissection reveals that cysts of tubular origin negative bacteria is essential. High bioavailability, communicate with the glomerulus proximally. One widespread distribution throughout body fluids and might suspect, therefore, that an antibiotic that is lipid solubility would be desirable. This simple set of filtered at the glomerulus might accumulate in a cyst requirements is actually surprisingly difficult to achieve, to the concentrations seen; quantitative studies, how-as illustrated in Table 1 . ever, do not support this. Several authors previously A final caveat to this is that much of the above have noted that even a single healthy nephron filtering comes from work on uninfected cysts. The pharmacoat 1×10−8 ml/h would take a week or so to deliver kinetics of infected cysts may well be very different, 1 ml of filtrate to a cyst, and this is not enough to and indeed one study has demonstrated that the normexplain the antibiotic accumulation seen [7, 8] . The ally non-penetrating aminoglycoside amikacin can be inevitable conclusion is that much movement of anti-found inside infected cysts [10] . biotics into cysts is transepithelial.
The choice of antibiotic to use in treating an infected Whilst the exact mechanism of cyst development polycystic kidney therefore remains an issue of debate. remains unknown, it is recognized that cysts retain Current guidance suggests that systemic sepsis be some of the histological and physiological characteristics of the epithelium from which they seem to mechanisms for this are influenced by cyst fluid pH and the diffusion constant (pK a ) of the antibiotic used. In a study of clindamycin accumulation in cysts, Adapted from Sklar et al. [4] and Elzinga and Bennett [9] . treated with intravenous ampicillin and an aminoglyco-References side, whilst recognizing that the failure of aminoglycos- occurring in 7% [12] . A similar study in 1996 suggested 11. Rossi SJ, Healy DP, Savani DV, Deepe G. High-dose ciprofloxrates of 16, 12 and 0% respectively [13] . The reasons 
Dietary interventions
decreased to normal or close to normal levels, or hypercalcaemia ensues. Recent reports suggest that The first modality of therapy is restriction of dietary calcium acetate is a more effective phosphate binder phosphate intake. The usual Western diet contains than is calcium carbonate [6 ] . It is known that its 800-2000 mg/day (26-67 mmol/day) of phosphate, effect does not depend on the gastric acid secretion. depending mainly on the protein content of the diet This is an advantage as many patients with advanced [1] . The major sources of dietary phosphate include renal failure are taking H2 blockers or have achlorhydmeat, fish, dairy products, certain vegetables, and soft ria. The incidence of hypercalcaemia, however, appears drinks. Processed foods usually contain significantly to be the same with both [6 ] . Although calcium salts more phosphate than natural products.
are effective phosphate binders, they are not without The phosphate content of the different diets preside-effects, including frequent development of hyperscribed to patients with renal failure varies between calcaemia and gastrointestinal symptoms. The com-550 and 1100 mg/day (18-36 mmol/day) [2, 3] .
bination of hypercalcaemia and hyperphosphataemia Decreasing dietary phosphate is very difficult to achieve may lead to extraosseous calcifications and possibly without significant reduction in protein intake.
calciphylaxis. As well, patient compliance is frequently Consequently, a diet that may help to maintain phosdifficult to achieve. phate balance and normal serum phosphate levels for Recently a significant phosphate-and parathya prolonged period carries the risk of malnutrition in roid hormone-lowering effect of calcium-alphapatients with progressive renal failure. Based on the ketoglutarate was demonstrated both in animals and evidence available, severe protein restriction cannot be in patients on chronic dialysis therapy. In a randomized advised in the treatment of progressive renal disease.
crossover study it caused fewer hypercalcaemic episIn patients with mild to moderate renal failure, a odes than did calcium carbonate [7] . However, as it is protein intake of 0.8-1.0 g/kg/day may be a reasonvery expensive, it is unlikely to become first-line able target that is both safe and acceptable for the therapy for hyperphosphataemia. patients. In patients on maintenance dialysis, who are
Recently several reports were published on the use usually catabolic, a diet containing more protein, of a novel agent, poly (allylamine hydrochloride) 1.0-1.2 g/kg/day, is needed to achieve neutral nitrogen (RenaGel ), which contains neither aluminium nor balance [4] . However, the above diets may contain calcium. It also seems to modulate serum lipid levels approximately 800-1200 mg (26-40 mmol ) of phosfavourably, lowering total cholesterol concentration.
phate. As the intestinal absorption ranges between
This agent is equally efficacious in phosphate binding 40 and 80% of the ingested phosphate, the amount as the calcium salts are [8] . Further studies, however, of absorbed phosphate varies between 10 and on the safety and efficacy of RenaGel are needed to 30 mmol/day or 70-210 mmol/week and usually find its final place in the treatment of hypercannot be matched by the decreasing phosphate excrephosphataemia. tion of the failing kidney or by the dialytic phosphate Another agent, phosphonophormic acid (PFA) was removal in patients on maintenance dialysis (see shown to inhibit sodium-dependent phosphate transbelow).
port in the proximal tubule of the rat and thereby increase the fractional excretion of phosphate [9] . PFA
Phosphate binders
is nephrotoxic; therefore it cannot be used in humans for the treatment of hyperphosphataemia. Similar drugs, however, might prove to be useful in patients As dietary restrictions are usually insufficient in maintaining phosphate balance and normal serum phos-with mild to moderate renal failure. phate levels, phosphate absorption from the gut needs to be reduced. This can be achieved by the use of Dialytic phosphate removal phosphate binders taken with meals. After recognition of the severe toxic effects caused by chronic administration of aluminium-containing medications, the use of The last modality of treatment of hyperphosphataemia is enhanced removal of phosphate by dialysis these has declined markedly. There seems to be no safe dose of aluminium that is not associated with progress-therapy. The average dialytic phosphate removal is 20-40 mmol/session with haemodialysis, i.e. ive aluminium accumulation in patients with renal failure. However, in approximately 15-25% of patients 60-120 mmol/week, and 70-85 mmol/week with CAPD. This means that many patients on dialysis are on maintenance dialysis, their application cannot be avoided completely [5] .
in net positive phosphate balance, even with optimal dietary compliance. Magnesium-containing antacids can reduce phosphate absorption effectively, but their use has generally Although it had been suggested that altering the buffer in the dialysate may increase the amount of been avoided because of the risk of hypermagnesaemia and the frequent development of diarrhoea.
phosphate removed, several papers later demonstrated that modification of the buffer does not lead to Currently calcium carbonate and acetate have been used more extensively as phosphate binders. The dose increased phosphate removal [10] . Haemofiltration or haemodialfiltration, by increasing the ultrafiltration of calcium carbonate can be increased gradually up to rate and thereby taking advantage of convective trans-within 5 months all patients changed to NHD became almost normophosphataemic. In fact they were able fer, seem to be somewhat more effective than conventional haemodialysis [10] , although the amounts to maintain acceptable serum phosphate levels (serum phosphate <1.8 mmol ), while increasing their phosremoved were still inadequate to maintain normal serum phosphate levels. Several reports have shown phate intake significantly, as well as discontinuing all their phosphate binders. During the study period the that the dialyser surface area and the predialysis serum phosphate level were the major determinants of dialytic mean phosphate intake rose from 25 to almost 40 mmol/day with serum phosphate levels <1.8 mmol. phosphate removal. Also it has been shown repeatedly that the type of dialyser membrane used did not affect This was achieved by dialysis therapy alone. the amount of phosphate removed [10, 11] .
From kinetic studies we know that during haemodia-
Conclusions
lysis the serum phosphate level drops rapidly in the first 1-2 h of treatment, and then reaches a plateau.
In spite of advances in the therapy of renal failure, the The amount of phosphate removed decreases significproblem of controlling serum phosphate has not yet antly in the second half of dialysis. It has also been been solved. One important method is to find new well documented that serum phosphate concentration phosphate binders that have fewer side-effects so that rises relatively quickly in the first few hours after patient compliance may be maintained. An alternative termination of dialysis (rebound phenomenon) [12] . approach is to find novel dialysis prescriptions by Accordingly, it was suggested that prolonging the which dialytic phosphate removal could be enhanced duration of dialysis or using larger, high efficiency to meet the phosphate content of a fairly liberal diet dialysers would not increase phosphate removal containing more than 1 g/kg protein daily. Recent further.
results utilizing daily dialysis protocols show promise As a result, there has been a search for increasing in meeting some of these goals. the efficacy of dialysis therapy to achieve better control of hyperphosphataemia. In Italy, Buoncristiani and co-workers have extensive experience with the use of References daily short dialysis sessions. They were able to achieve remarkable blood purification and showed that many with dialysis alone would allow for our patients to [1440] [1441] [1442] [1443] [1444] [1445] consume an average 'western diet' containing 10 phosphate was also demonstrated. We showed that Introduction tional cellulosic dialysis membranes, i.e. a molecular weight <10 000 Da. Among the commonest symptoms in patients suffering from uraemic intoxication are anorexia, nausea and vomiting, which typically develop when the glomerular Nutritional requirements in uraemia filtration rate is <10-15% of normal and increase in severity with progression towards end-stage renal fail-The requirements for protein appear to be higher in ure. Data from the MDRD study (Modification of dialysis patients than in healthy persons. This has been Diet in Renal Disease) in the US [1] show that an attributed, inter alia, to dialytic losses of amino acids adaptive reduction in the intake of protein may start and, in peritoneal dialysis, also protein. Other factors early during the development of renal failure (glomer-which may enhance net protein catabolism and increase ular filtration rate 25-30 ml/min), associated with protein requirements are low energy supply, metabolic reduction in energy intake and various nutritional acidosis and co-morbid conditions (peritonitis, other parameters. More recently, a prospective analysis of infections, systemic disease, etc.) [5, 6 ] . Generally, a protein intake by patients with chronic renal disease protein intake of 1.2 g/kg body weight/day is recomwas reported, showing that patients tended to restrict mended for dialysis patients, i.e. much higher than the their protein intake spontaneously (evaluated from level of protein intake (0.75 g/kg body weight/day) 24 h urea excretion) with the progression of renal which is considered safe for healthy adults. failure, to <0.6 g/kg body weight/day, when creatinine Energy requirements depend on the level of physical clearance fell below 10 ml/min [2] .
activity, an intake of 35-40 kcal/kg of body weight/day A plausible explanation of this is that inhibition of being recommended for adults not performing heavy appetite is caused by retention in body fluids of one physical exercise. Ikizler and Hakim recently have or more toxic substances as a consequence of reduced reported that resting energy expenditure (REE) is renal function. Conservative treatment of renal failure actually higher in haemodialysis (HD) patients, even with a low protein diet may alleviate temporarily or on non-dialysis days, compared with age-, sexforestall uraemic symptoms in the form of anorexia, and body mass index-matched normal controls [7] . nausea and vomiting, suggesting that one or more of However, other studies in HD and continuous ambuthese toxins are generated by breakdown of dietary latory peritoneal dialysis (CAPD) patients do not show protein. Signs of malnutrition are common in end-that energy expenditure for a given physical activity stage renal disease patients at the start of maintenance differs from that in normal subjects [8] . dialysis treatment and appear to be prognostically unfavourable [3, 4] .
Nutritional intakes in dialysis patients
After dialysis therapy is started, these symptoms are partly relieved or they disappear within a few days. Such observations indicate that one or more uraemic The mean intake of protein is <1 g/kg of body toxins causing these symptoms have a molecular size weight/day in a large proportion of patients on maintenance HD [9] , which suggests that requirements for optimal protein intake are not met. A large proportion Correspondence and offprint requests to: Dr Abdel-Hafiz Mamoun, of CAPD patients also ingest considerably lower Department of Renal Medicine, K56, Huddinge University Hospital, S-141 86 Huddinge, Sweden. amounts of protein than the recommended intake [10] .
The energy intake, like the protein intake, is often also better preserved on CAPD than on HD. After the start of CAPD, the patients generally experience increased low in groups of HD patients, i.e. the mean intake has been reported to be 26-29 kcal/kg of body weight/day well-being and improvement in appetite. However, some patients may become underdialysed and fail to [11] . The total energy intake may also be low in CAPD patients, despite the continuous supply of energy by thrive, along with a reduction in residual renal function. glucose absorbed from the dialysis fluid [11] .
In most studies showing a correlation between Kt/V (or creatinine clearance) and protein intake, the sum Anorexia, dose of dialysis and residual renal of peritoneal and renal Kt/V or creatinine clearance function was used in the calculation. However, multiple regression analysis of data in CAPD patients from our unit showed that the residual renal function correlated with Several studies in HD and CAPD patients report a correlation between the dose of dialysis for small-the protein intake, whereas the dose of peritoneal dialysis had no significant effect [10] . These results molecule removal ( Kt/V urea ) and the protein intake, especially in the lowest dose intervals [12] . It has been suggest that the residual renal function is more important for appetite than the dose of peritoneal dialysis. found that the relationship between Kt/V urea and protein intake in CAPD patients, estimated from the urea The pivotal role of residual renal function is supported further by longitudinal studies showing that total body appearance rate, differed from that in HD patients [12] . At the same low Kt/V urea levels, the estimated nitrogen decreases during the first 2 years of CAPD treatment, concomitantly with a decrease in protein protein intake was higher in CAPD patients than in HD patients and the protein intake increased more for and energy intake [15] and that protein intake (estimated from urea appearance) decreases, along with the the same increase in Kt/V urea in CAPD than in HD patients. In small groups of dialysis patients, it has loss of residual renal function [16 ] . An international cross-sectional multicentre study showed that lack of been shown in prospective studies that an increase in the dose of dialysis results in a significant increase in renal function is associated with anorexia and symptoms of severe malnutrition [17] . the estimated protein intake [13] .
The intake of protein was assessed by urea kinetic These findings are in line with our hypothesis that one or more compounds that cause anorexia in uraemic modelling, based on the concept that the amount of urea generated reflects the net amount of protein patients are normally excreted by the kidneys. This hypothesis is supported by our observation [18] that catabolized which gives an estimate of the protein intake, at least when patients are in metabolic steady food intake in the rat is inhibited after intraperitoneal injection of a 1000-5000 Da middle-molecule fraction, state and not markedly catabolic or anabolic. It has been argued [14] that the relationship between Kt/V urea isolated from normal urine and corresponding to the fraction from uraemic plasma ultrafiltrate, which has and protein intake (urea appearance) reflects mathematical coupling rather than a biological relationship, a similar effect. since the two variables are, to some extent, interdependent: both are normalized to body size and both
Anorexia and the middle molecules
are dependent on urea determination in plasma preand post-dialysis. However, some data show a relationship between the quantity of urea removed and protein We assessed food intake quantitatively by measuring the consumption of intraorally infused nutritional soluintake, calculated from the dietary records and interviews. In CAPD patients, this relationship could be tions in conscious, free-moving rats. This model has been used earlier in neuropharmacological studies of demonstrated even when the quantity of urea or creatinine removed was not normalized to body size [10] .
food intake, and has proved to be accurate and highly reproducible, especially because the same group of An attractive hypothesis has been proposed to explain the difference in the relationship between animals can be studied repeatedly on consecutive days and can serve as their own controls. Kt/V urea and protein intake (estimated from urea appearance) in CAPD patients compared with HD Using this new method as a bioassay, we have started to isolate and characterize factors in uraemic patients, i.e. that molecules of a molecular size larger than urea-so-called middle molecules-cause anor-plasma and normal urine which suppress appetite. We collected and pooled ultrafiltrate obtained from endexia. Such hypothetical molecules would be dialysed more efficiently by the peritoneal membrane than by stage renal failure patients at the beginning of their first dialysis treatment. Ultrafiltrate from pooled an HD membrane. The hypothesis that middlemolecule compounds cause anorexia is also in keeping normal plasma and normal urine was obtained in vitro by filtration through the same type of dialyser used in with the observation in HD patients by Lindsay and Spanner [12] . These authors found that protein intake, the patients. Uraemic ultrafiltrate and normal urine, which had not been concentrated or otherwise modiestimated from the urea appearance, increased proportionally more for a given increase in Kt/V urea in patients fied, injected into rats with normal renal function, inhibited the ingestion of carbohydrate and protein. treated with high-flux than with low-flux membranes.
At the start of maintenance dialysis, most patients The absence of an effect on food intake of the nonuraemic ultrafiltrate and normal saline supports the have some residual renal function which seems to be conclusion that the inhibition of the uraemic ultrafil-by activation of the hepatic membrane potential that inhibits food intake by signalling to the brain via the trate is a feature of uraemic intoxication and that the test system is appropriately reliable. This implies that hepatic vagus nerve. However, to be effective i.v., these middle-molecule fractions must be given in higher one or more toxic factors that normally are eliminated from the body by excretion of urine accumulated in doses to reach their site(s) of action, because they are diluted in the general circulation. the body fluid of patients with renal failure and suppressed food intake. However, we do not know if the We observed that fractions in the middle-molecule weight range, isolated from uraemic plasma and urine effect of normal urine and uraemic ultrafiltrate is mediated by the same substance or by various ultrafiltrates, inhibit food intake in a dose-dependent manner when injected into the lateral brain ventricle. substances.
Fractions of the pooled ultrafiltrates of various However, the effect of the middle molecules on the brain-feeding centre remains unclear, and our limited molecular sizes (0.1-0.5, 0.5-1, 1-5 and 5-10 kDa) were isolated and concentrated by serial filtration, knowledge of their molecular weight, transport through the blood-brain barrier and their availability using membranes with known cut-offs. The subfractions of uraemic ultrafiltrate, having a molecular weight to the brain warrant further investigations. Nevertheless, these results suggest that middle molecules ranging from 1 to 5 kDa and 5 to 10 kDa, inhibit ingestion in a dose-dependent manner, whereas frac-directly inhibited food intake via a central mechanism, as documented by direct injection into the lateral brain tions having molecular weights <1 kDa are inactive. An ultrafiltrate of normal urine also inhibited appetite, ventricle. This mechanism may be complementary to the splanchnic pathway described above. an effect entirely confined to a fraction with a molecular weight of 1-5 kDa. These results support the hypothesis that middle-molecule compounds, some of which Conclusion normally are eliminated by urinary excretion, accumulate in the plasma of uraemic patients and suppress
Anorexia is common in end-stage renal failure patients food intake [18] .
and contributes to the development of protein-energy malnutrition, which is strongly associated with increased morbidity and mortality. One or more dialys- [1] . This self-limiting induce eosinophilia when introduced into the peritonprocess has not been demonstrated to cause permanent eum of mice by activating the coagulation mechanism adverse effects on the peritoneal membrane function, and to produce the eosinophilotactic fibrin. A growing treatment usually is not required. It has been described body of evidence suggests that peritoneal fluid eosinounder various terminologies, but the term 'peritoneal philia may be due to the chronic inflammatory process fluid eosinophilia' should be preferred to distinguish it that persists in the peritoneum of peritoneal dialysis as a clinical entity with diagnostic considerations separate patients [6, 7] . Cytokines, chemokines, chemoattracfrom those of known infectious aetiological processes.
Role of splanchnic-brain signalling in anorexia of
tants and other inflammatory mediators released into The significance of peritoneal fluid eosinophilia is this inflammatory site up-regulate pre-formed molecuncertain. In general, the stimulatory and inhibitory ules and de novo synthesis of adhesion molecules [8] . effects of eosinophils in various allergic and inflam-These adhesion molecules are important for immune matory disease states is now well established. They regulatory mechanisms concerning antigen presentahave been implicated in, amongst others, progressive tion, intercommunication and activation of immune morphological changes occurring in glomerulo-cells, localization and migration as well as effectorsclerosis, arterial obliteration, interstitial nephritis and target cell interactions in inflammatory processes. The chronic vascular rejection of renal allografts [2, 3] . The incidence and intensity of the peritoneal eosinophil percentage of hypodense eosinophils, i.e. activated accumulation may be due to the local balance of proeosinophils with increased metabolic activity, has been and anti-inflammatory mediators, the up-regulation of shown to increase in peritoneal fluid eosinophilia and the quantity and avidity of adhesive receptors and decrease with resolution of the entity [4] . These obser-their ligands by systemic and peritoneal cytokines, the vations and newer understanding of the physiology of organ specificity to adhesion molecule pathways and eosinophils suggest that peritoneal fluid eosinophils the differential cell surface distribution of adhesion may not be mere innocent bystanders in peritoneal molecules expressed constitutively [9, 10] dialysis, but may have a pathophysiological function
The concept of adhesion molecules brings a new such as a host defence function in inactivating inflam-perspective to our understanding of peritoneal fluid matory mediators in the peritoneum eosinophilia. While it may not explain all of our dilemmas, it probably signals a paradigm shift in our The recruitment of eosinophils into the peritoneum approach to this intriguing phenomenon. during peritoneal dialysis is not explained solely by hypersensitivity reactions to constituents of the peritoneal dialysis systems and medications [5] Introduction tumour lysis syndrome. Likewise, the improvement of cryopreservation and marrow infusion modalities perAcute renal failure (ARF ) after bone marrow transmitted to largely avoid today the uncommon cases of plantation (BMT ) is a frequent event, with a 30-80% ARF during the 3 first days [3] . Veno-occlusive disease occurrence rate [1] [2] [3] [4] , and a constant worry to the of the liver is now the main complication of this initial clinicians because of its management difficulties and period, because of the inevitable endothelial injury its ominous prognosis. Chronic renal failure is less resulting from pretransplant chemoradiation therapy. usual, because it is often the consequence of severe Most cases of veno-occlusive disease are clinically ARF, a complication associated with a high mortality obvious with jaundice, liver pain, oedema, and ascites. rate in the first 3 months post-BMT. Furthermore, They are sometimes followed by ARF mimicking the chronic cyclosporin nephrotoxicity is rarely encounhepatorenal syndrome, with a 75% mortality rate. tered because cyclosporin (CsA) is withdrawn at 6 Many treatments have been tried to prevent venomonths. Whichever the renal dysfunction mechanism, occlusive disease, but none of them have proved to be the aetiological and therapeutic approaches have effective. Haemodialysis is rarely required, but if it is to take into account the haematological context: allothe risk of hypovolaemia should be borne in mind [5] . genic or autologous BMT, conditioning therapy, haematological risk factors, graft-versus-host-disease (GVHD), underlying diseases recurrence-risk, age, Period 2 veno-occlusive disease.
After 2 weeks, the early complications can still be observed (veno-occlusive disease or delayed graft function and their infectious consequences), but acute
During the first year post graft, four periods evolve GVHD is the main risk in recipients of an allogeneic from the classical haematological complications graft. While acute GVHD of low grade could contribintricated with ARF ute to prevention/treatment of leukaemic relapse, GVHD of grade >1 may cause serious lesions of skin, Period 1 liver, and gut. Renal dysfunction is caused by several mechanisms. (i) Hypovolaemia: skin and gut lesions The first 2 weeks are a crucial period, when aplasia is may cause hypovolaemia, which is often difficult to an obligatory event with a major risk of sepsis. The manage in the context of malnutrition. (ii) Infection: prognosis has improved through isolation in laminar high-grade GVHD often requires prolonged, high-dose airflow rooms. However, the risk of tubular necrosis corticosteroid therapy, and sometimes antilymphocyte persists during severe sepsis, and the large use of globulin, frequently giving rise to severe infections antibiotics and antifungal agents increases the risk of (CMV disease, bacterial and fungal sepsis). (iii) drug nephrotoxicity. Patient selection and the prophyNephrotoxic drugs: the risk of ARF is further increased lactic use of volume expansion, urinary alkalinization, when septic patients are exposed to nephrotoxic drugs such as aminoglycosides and amphotericin B. (iv)
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Haemolytic-uraemic syndrome: severe acute GVHD leads to TNF-a release [6 ] , which contributes to endo-thelial injury, and which in turn may account for HUS The deleterious effects of CsA on renal haemodynamics could enhance the severity of other forms of [7] . Because haemolysis and thrombocytopenia are frequently encountered for many reasons other than renal dysfunction and render their management difficult. It is impossible to define a minimal effective CsA HUS, schizotocytes, indices of haemolysis, and occurrence of hypertension are valuable signs pointing to trough level. Pharmacological survey is essential, because drug interactions and interindividual varithe presence of HUS. The incidence of HUS is underestimated, as kidney biopsy is not often performed ations are frequent. Under NeoralB, blood peak value can help to detect the patients who are most exposed because of the higher risk in this situation. Because the different pathomechanisms are often operative sim-to the acute haemodynamic effects of the drug on the kidney. Such patients may then be switched to three ultaneously, it is often difficult to ascribe renal impairment to one simple mechanism.
divided doses instead of two to be on the safe side. Irrespective of its haemodynamic toxicity, the procoagulant effect of CsA facilitates the occurrence of HUS Period 3 during GVHD. The procoagulant effect resulting from From the third month onwards, persistence or appear-TNF-a release by GVHD may also be potentiated by ance of clinical signs of GVHD indicate the develop-CsA. CsA alone usually does not fully explain the ment of chronic GVHD. This period is a turning point: occurrence of HUS. One should always look for an the absence of chronic GVHD increases in the risk of associated clinical cause, particularly haematological relapse of the initial haematological illness. On the or infectious causes. No form of symptomatic treatother hand, if severe chronic GVHD is not well under ment has proved its efficacy (this is also true for control the patient is exposed to a high risk of HUS. plasmapheresis). Clinical improvement will only be The diagnosis is easier at this point in time because possible when the initial cause of endothelial injury the clinical context is less confounding than in the can be controlled. It is necessary to decrease the dose earlier periods.
of CsA, but it makes the control of GVHD difficult.
In this case, one may consider the use of mycophenolPeriod 4 ate mofetil; this will be permit withdrawal of CsA and also avoid azathioprine, a drug classically prescribed, After 6 months, persistence or occurrence of renal but with well-known bone marrow toxicity. failure carries a grave prognosis.
Contrary to what is seen after cardiac transplantaThe presence or absence of chronic GVHD indicates tion, chronic renal failure due to a direct chronic whether or not HUS is a likely diagnosis in an allograft nephrotoxicity of CsA is uncommon, because CsA is recipient with renal failure. When HUS occurs after withdrawn 6 months after BMT. more than 6 months in a recipient of an autologous
The conditioning chemoradiation therapy plays cer-BMT (with no risk of GVHD and no use of CsA), tainly a role in determining whether chronic renal clearly the possibility of endothelial injury resulting failure occurs after an acute episode of HUS. from other mechanisms must be considered. Such cases of delayed renal failure, particularly a nephritic syndrome or HUS are often a sequel of radiation nephritis Does acute renal failure contribute to patient with mesangiolysis and arteriolonecrotic lesions. The mortality? diagnosis can be made by renal biopsy [8] . The longterm outcome of this renal complication seems to be After allogenic BMT, early mortality up to 6 months the same as for classical radiation nephritis. A prophyis 40%, and ARF is a major prognostic factor by lactic measure is fractionation of doses during initial univariate analysis, but hyperbilirubinaemia is also total body irradiation [9, 10] . Finally, some forms of identified as a mortality risk factor. In fact ARF and glomerulonephritis, e.g. minimal-change disease, have hyperbilirubinaemia often accompagny the main combeen described in patients experiencing a chronic plications encountered after allogenic BMT (grade Á2 GVHD [11] .
acute GVHD, veno-occlusive disease, HUS, heavy sepsis) which are themselves significantly associated
What is the role of CsA for renal impairment after with a high mortality rate. Thus, performing a multivabone marrow transplantation ?
riate analysis to select stepwise variables that are significant and independent of each other, sepsis and hyperbilirubinaemia clearly appeared to persist as high The use of CsA contributes markedly to the occurrence of ARF. Its nephrotoxicity is well known. The great risk factors for mortality in contrast to ARF that was no longer significantly associated with mortality. In variations of the incidence of ARF between different teams may well be related to differences in the use of the absence of hyperbilirubinaemia, ARF has no deleterious effect on the survival rate at 1 year. In fact, in CsA. When a moderate increase in serum creatinine responds well to a decrease in the dose of CsA, the multivariate analysis, hyperbilirubinaemia is highly predictive of the development of ARF and often precause is obviously CsA and this is seen in up to 80% of cases. Reduction of the dose of CsA poses the risk cedes it. Thus the association of hyperbilirubinaemia and ARF has ominous implications for patient survival of under-immunosuppression. This may trigger or aggravate GVHD [12] . rate [13] .
Introduction
lessens considerably the costs of treatment of end-stage Because of the better chances of maintaining a better renal disease, it avoids the inconvenience of frequent quality of life, it is widely accepted that renal trans-hospital visits and/or frequent peritoneal dialysate plantation is the treatment of choice for a substantial exchanges, it avoids dialysis associated morbidity and proportion of patients with end-stage renal disease. In access surgery and perhaps most of all, it facilitates general, transplantation is performed after a varying social and vocational rehabilitation. In a retrospective period of chronic haemo-or peritoneal dialysis. The case-control study performed at the University of Texas other option of transplanting patients not yet on renal Medical School in 85 cases of pre-emptive transplantareplacement therapy, so called pre-emptive trans-tion, it was found that, compared with the matched plantation, has been much less popular. A recent control patients transplanted after a minimum of 6 analysis of the ERA-EDTA Registry data showed that months' chronic dialysis therapy, significantly more pre-emptive transplantation in Europe is rarely used patients who had received a transplant before being in adults, but that its frequency differs remarkedly on dialysis, were employed 6 months post-transplant among European countries [1] . In Sweden 70% of [2] . children entering renal replacement therapy receive renal transplantation prior to dialysis. In Norway almost 15% of adult patients receive a pre-emptive Potential concerns transplantation whilst in countries like Austria, Germany. and Ireland, pre-emptive transplantation is In the past some concern has been expressed towards nonexistant.
worse results in patients transplanted prior to dialysis compared to patients transplanted after having been on dialysis for some time. On the one hand, this was
